With annually 2 million deaths and 9 million new cases, there are more victims of tuberculosis than of any other infectious disease, apart from AIDS.

Worsening the situation, many strains of tuberculosis are so resistant that they no longer respond to traditional treatment, making the necessity of a new tuberculosis vaccine more urgent than ever.

For the first time in 80 years, a promising live tuberculosis vaccine has reached the clinical trial stage in Germany.